Natalizumab adverse events are rare in patients with multiple sclerosis.
Fragoso YD, Alves-Leon SV, Arruda WO, Carvalho Mde J, Comini-Frota ER, Corrêa ÉC, Ferreira ML, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Mendes MF, Morales RR, Muniz A, Salgado PR, Ruocco HH, Albuquerque LB, Brooks JB, Fêzer L, Georgetto S, Lopes J, Malfetano FR, Meira ID, Oliveira CL, Oliveira FT, Safanelli F, Satomi M.
Fragoso YD, et al.
Arq Neuropsiquiatr. 2013 Mar;71(3):137-41. doi: 10.1590/s0004-282x2013000300002.
Arq Neuropsiquiatr. 2013.
PMID: 23563711
Free article.